{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:30:22Z","timestamp":1780374622993,"version":"3.54.1"},"reference-count":65,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.29917","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T18:30:43Z","timestamp":1607970643000},"page":"e2029917","source":"Crossref","is-referenced-by-count":30,"title":["Lung Cancer Survival in Patients With Autoimmune Disease"],"prefix":"10.1001","volume":"3","author":[{"given":"Saya","family":"Jacob","sequence":"first","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Rahbari","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Tegtmeyer","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Zhao","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tran","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Helenowski","sequence":"additional","affiliation":[{"name":"Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Walunas","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Center for Health Information Partnerships, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Department of Medicine, Northwestern Scleroderma Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Dematte","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Division of Pulmonary and Critical Care, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Villaflor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois"},{"name":"City of Hope Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"10","key":"zoi200945r3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases.","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"6167","key":"zoi200945r4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer.","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"issue":"1","key":"zoi200945r5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"zoi200945r6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/0961203313520060","article-title":"Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.","volume":"23","author":"Ni","year":"2014","journal-title":"Lupus"},{"issue":"9","key":"zoi200945r7","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies.","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"zoi200945r8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study.","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"issue":"5","key":"zoi200945r9","first-page":"615","article-title":"Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.","volume":"32","author":"Chen","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"zoi200945r10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.canep.2013.04.014","article-title":"The risk of cancer development in systemic sclerosis: a meta-analysis.","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"zoi200945r11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"zoi200945r12","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"zoi200945r13","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis.","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"issue":"3","key":"zoi200945r14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"zoi200945r15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/ard.2006.056424","article-title":"Risk factors for lung cancer in patients with scleroderma: a nested case-control study.","volume":"66","author":"Pontifex","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"zoi200945r16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/acr.22751","article-title":"Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012.","volume":"68","author":"Rees","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"zoi200945r17","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.21037\/jtd","article-title":"Lung cancer and interstitial lung disease: a literature review.","volume":"10","author":"Naccache","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"zoi200945r18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/res.2009.14.issue-3","article-title":"Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer.","volume":"14","author":"Mizuno","year":"2009","journal-title":"Respirology"},{"issue":"12","key":"zoi200945r19","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","article-title":"The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK.","volume":"101","author":"Le Jeune","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"zoi200945r20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1164\/ajrccm.161.1.9906062","article-title":"Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study.","volume":"161","author":"Hubbard","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"zoi200945r21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis.","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"zoi200945r22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00393-016-0043-0","article-title":"[Lung cancer and rheumatoid arthritis: an interdisciplinary challenge].","volume":"75","author":"Rubbert-Roth","year":"2016","journal-title":"Z Rheumatol"},{"issue":"12","key":"zoi200945r23","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1073\/pnas.92.12.5258","article-title":"The causes and prevention of cancer.","volume":"92","author":"Ames","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"zoi200945r24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy.","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"zoi200945r25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development.","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"zoi200945r26","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.","volume":"15","author":"Graus","year":"1997","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi200945r27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamaoncol.2017.2925","article-title":"Association of immune-related adverse events with nivolumab efficacy in non-small-cell lung cancer.","volume":"4","author":"Haratani","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi200945r28","first-page":"81","article-title":"Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab.","volume":"11","author":"Giannicola","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"zoi200945r29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117829","article-title":"Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional study.","volume":"10","author":"Katzen","year":"2015","journal-title":"PLoS One"},{"key":"zoi200945r30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12885-016-2444-5","article-title":"Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.","volume":"16","author":"Park","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"zoi200945r31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/acr.22997","article-title":"Impact of rheumatoid arthritis on the mortality of elderly patients who develop cancer: a population-based study.","volume":"69","author":"Nayak","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"zoi200945r32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.lungcan.2017.11.024","article-title":"How does autoimmune disease impact treatment and outcomes among patients with lung cancer? a national SEER-Medicare analysis.","volume":"115","author":"Khan","year":"2018","journal-title":"Lung Cancer"},{"issue":"9","key":"zoi200945r33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis.","volume":"308","author":"Lopez-Olivo","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"zoi200945r34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/ard.2008.094904","article-title":"Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.","volume":"68","author":"Bongartz","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"zoi200945r35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10067-015-3026-7","article-title":"Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.","volume":"34","author":"Berghen","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"11","key":"zoi200945r36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape.","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"zoi200945r37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship.","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell Immunol"},{"issue":"1","key":"zoi200945r38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0961203308093923","article-title":"Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis.","volume":"18","author":"Lee","year":"2009","journal-title":"Lupus"},{"issue":"6","key":"zoi200945r39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J Exp Med"},{"issue":"4","key":"zoi200945r40","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance.","volume":"203","author":"Keir","year":"2006","journal-title":"J Exp Med"},{"issue":"29","key":"zoi200945r41","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1\u2013deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi200945r42","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3389\/fimmu.2018.02306","article-title":"Immune checkpoints as therapeutic targets in autoimmunity.","volume":"9","author":"Paluch","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"zoi200945r43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi200945r44","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat Genet"},{"issue":"4","key":"zoi200945r45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"zoi200945r46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI16015","article-title":"Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.","volume":"111","author":"Dong","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"zoi200945r47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer.","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"zoi200945r48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"5","key":"zoi200945r49","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment.","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"issue":"5","key":"zoi200945r50","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells.","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"issue":"10","key":"zoi200945r51","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"zoi200945r52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","article-title":"The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects.","volume":"137","author":"Grimbacher","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"zoi200945r53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer.","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"zoi200945r54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2016.131","article-title":"Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?","volume":"12","author":"van der Vlist","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"zoi200945r55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0065-2776(08)60624-0","article-title":"Gene transfer as cancer therapy.","volume":"58","author":"Dranoff","year":"1995","journal-title":"Adv Immunol"},{"issue":"6832","key":"zoi200945r56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"issue":"7637","key":"zoi200945r57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point.","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"87","key":"zoi200945r58","first-page":"123","article-title":"Interferon-? and systemic autoimmunity.","volume":"16","author":"Pollard","year":"2013","journal-title":"Discov Med"},{"issue":"16","key":"zoi200945r59","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1158\/1078-0432.CCR-17-3451","article-title":"Interferon gamma messenger RNA signature in tumor biopsies predicts outcomes in patients with non\u2013small cell lung carcinoma or urothelial cancer treated with durvalumab.","volume":"24","author":"Higgs","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"3","key":"zoi200945r60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S1010-7940(97)00198-X","article-title":"Disease recurrence after resection for stage I lung cancer.","volume":"12","author":"al-Kattan","year":"1997","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9202","key":"zoi200945r61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(00)82038-3","article-title":"Lung cancer.","volume":"355","author":"Hoffman","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"zoi200945r62","first-page":"242","article-title":"Recurrence after surgery in patients with NSCLC.","volume":"3","author":"Uramoto","year":"2014","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"zoi200945r63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jtcvs.2014.08.086","article-title":"Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.","volume":"149","author":"Sato","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"zoi200945r64","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.athoracsur.2011.06.055","article-title":"Survival after surgery for pathologic stage IA non\u2013small cell lung cancer associated with idiopathic pulmonary fibrosis.","volume":"92","author":"Saito","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"zoi200945r65","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1200\/JCO.2016.69.4166","article-title":"Antineoplastic treatment of advanced-stage non\u2013small-cell lung cancer: treatment, survival, and spending (2000 to 2011).","volume":"35","author":"Bradley","year":"2017","journal-title":"J Clin Oncol"},{"key":"zoi200945r1","unstructured":"World Health Organization. Cancer. Accessed April 15, 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"zoi200945r2","unstructured":"American Cancer Society. Lung cancer risk factors. Accessed April 15, 2020. https:\/\/www.cancer.org\/cancer\/lung-cancer\/prevention-and-early-detection\/risk-factors.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2774100\/jacob_2020_oi_200945_1607354071.76105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:18:41Z","timestamp":1697354321000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2774100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29917","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}